Foresite Capital is a private equity firm in California that provides catalytic capital to transformative healthcare companies at all stages. Founded 2011 in San Francisco, California, United States by Jim Tananbaum, this private equity firm invests in private equity, early stage ventures and late stage ventures. Its portfolio companies include Genapsys, Aimmune Therapeutics, Generation Bio, Element Biosciences, and Kinnate Biopharma. As of February 2020, Foresite Capital has made 66 investments. Their most recent investment was on Jan 11, 2020, when Generation Bio raised $110M. Foresite Capital has had 27 exits. Foresite Capital's most notable exits include Aimmune Therapeutics, Twist Bioscience, and Alector. The company has raised 4 funds, their latest being Foresite Capital Fund IV. This fund was announced on May 3, 2018 and raised a total of $668M. The company prefers to invest in the healthcare, therapeutics, devices, diagnostics and services sectors.
A DNA synthesis company using a next-generation silicon-based technology platform.
Decibel Therapeutics conducts inner ear research to deliver medicines for hearing and balance.
A biotechnology company offering a genomics platform supporting scientific research into life sciences such as oncology, immunology, and neuroscience.
A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.
Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.
A company developing DNA sequencing technologies and systems
A gene editing technology company founded in 2015 and based in Boulder, CO, USA.
DNAnexus is a Mountain View, California-based cloud computing and bioinformatics company.
Relay Therapeutics is a Cambridge, Massachusetts-based developer of an allosteric drug-discover platform that is intended to apply computational techniques to protein motion.
Juvenescence is a venture capital and development company focused on developing therapies targeting aging, age-related disease and regeneration.
Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies
Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company focused on solving Duchenne muscular dystrophy.
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases.
Evonetix is a synthetic biology company
Cue Health is a San Diego-based medical device company working to track health information at the molecular level.
Generation Bio is a biotechnology company that was founded in 2016
Neuroscience precision therapy company
ALX Oncology is a Burlingame, California-based biotechnology company working on pre-clinical stage immuno-oncology therapies.
Replimune Group, Inc. is a clinical-stage biotechnology company.
Maze Therapeutics is a San Francisco-based biotechnology company developing genetics-based therapeutics
Associated investment funds
Documentaries, videos and podcasts